AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glynova-M 2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Tycoon Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glynova-M 2 Tablet SR

Diabex Duo SR tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose levels. Diabex Duo SR should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to hyperglycemia, increasing the risk of complications including nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication forms part of a comprehensive diabetes management plan, necessitating dietary adjustments, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar). Learn to identify symptoms like sweating, vertigo, cephalgia, and tremors, and know how to manage them promptly. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption elevates hypoglycemia risk and should be minimized. Other potential side effects encompass altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Consult your doctor before use if pregnant or breastfeeding. Regular blood glucose monitoring is vital, along with potential blood tests to track blood cell counts and liver function.

Uses of Glynova-M 2 Tablet SR

Managing type 2 diabetes

Major Benefits of Glynova-M 2 Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glynova-M 2 Tablet SR whole; do not chew, crush, or divide it. Administer this medicine with food.

Common Side effects of Glynova-M 2 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glynova-M 2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glynova-M 2 Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Take this medication with a meal.

How Glynova-M 2 Tablet SR works:

Glynova-M 2 SR tablets combine glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glynova-M 2 Tablet SR and alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glynova-M 2 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Medical advice is recommended.

Breast feedingBreast feedingUNSAFE

Sustained-release Glynova-M 2 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired if your blood glucose levels are abnormally low or elevated. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Glynova-M 2 Tablet SR cautiously, potentially requiring dose modification. Severe kidney disease contraindicates its use. Regular kidney function monitoring is advised during treatment. Physician consultation is essential.

LiverLiverCAUTION

Individuals with hepatic impairment should use Glynova-M 2 Tablet SR cautiously, potentially requiring dosage modifications. Consultation with a physician is advised. A reduced initial dose is typically prescribed for patients with mild to moderate liver disease; however, its use is contraindicated in those with severe liver dysfunction.

What if you forget to take Glynova-M 2 Tablet SR :

Should you forget a Glynova-M 2 Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glynova-M 2 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glynova-M 2 Tablet SR

Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glynova-M 2 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glynova-M 2 Tablet SR and seek immediate medical attention.
Glynova-M 2 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with a healthy diet and regular exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for treating type 1 DM.
Glynova-M 2 Tablet SR may cause common side effects such as low blood sugar, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glynova-M 2 Tablet SR use can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, supplemental Vitamin B12 is recommended at least annually by some researchers.
Glynova-M 2 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glynova-M 2 Tablet SR and alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glynova-M 2 Tablet SR
77
MRP 89
13% off